About This Source - Global News
Global News is the news and current affairs division of the Canadian Global Television Network, based in Vancouver, Canada.
Recent from Global News:
Global News published this video item, entitled “Alberta stops first dose COVID-19 vaccine appointments due to supply issues | FULL” – below is their description.
Alberta has stopped administering first doses of the Oxford-AstraZeneca COVID-19 vaccine.
According to the province’s chief medical officer of health Dr. Deena Hinshaw the change is being made “based on global supply challenges.”
The remaining supply of the vaccine we be available for second doses or anyone who may have a contraindication to mRNA vaccines like the Moderna or Pfizer COVID-19 vaccine.
All future first dose vaccines in the province will be booked utilizing Moderna or Pfizer vaccines, unless there is a contraindication.
Dr. Hinshaw said on Tuesday that “no decision have been made” on whether Albertans who received a first dose of AstraZenca vaccine could be able to receive an mRNA vaccine for the second dose.
“We are reviewing all the available evidence, and awaiting the results of clinical trials in the U.K.” Dr. Hinshaw continued.
Alberta Premier Jason Kenney said on Tuesday that it’s expected more than 270,000 doses of vaccine will be administered in the next seven days. Alberta recorded an immunization record on May 6, with 59,492 doses of vaccine going into arms in just one day.
By Wednesday, Kenney said two million COVID-19 shots will have been given to Albertans, calling it a “big milestone for our province.”
For more info, please go to https://globalnews.ca/news/7850968/alberta-stops-first-doses-astrazeneca-vaccine/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#Alberta #Coronavirus #COVID19 #GlobalNews #abpoliGlobal News YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.
In This Story: AstraZeneca
AstraZeneca plc/AB (LON: AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Södertälje, Sweden. Its R&D is concentrated in Cambridge in United Kingdom, Södertälje in Sweden, and Maryland and Toronto in North America.
3 Recent Items: AstraZeneca
In This Story: COVID-19
Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.
Symptoms of coronavirus
The main symptoms of coronavirus are:
- a persistent new cough (non productive, dry)
- a high temperature (e.g. head feels warm to the touch)
- shortness of breath (if this is abnormal for the individual, or increased)
Latest News about Covid-19
Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.
5 Recent Items: COVID-19
In This Story: Moderna
Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.
CEO: Stéphane Bancel (2011–)
Stock ticker: (NASDAQ:MRNA)
5 Recent Items: Moderna
In This Story: Pfizer
Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.
5 Recent Items: Pfizer
In This Story: Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.